- Home
- NUVB vs THR Comparison
NUVB vs THR Comparison
Compare NUVB & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- THR
- Stock Information
- Founded
- NUVB 2018
- THR 1954
- Country
- NUVB United States
- THR United States
- Employees
- NUVB N/A
- THR N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- THR Industrial Machinery/Components
- Sector
- NUVB Health Care
- THR Energy
- Exchange
- NUVB Nasdaq
- THR Nasdaq
- Market Cap
- NUVB 679.9M
- THR 906.5M
- IPO Year
- NUVB N/A
- THR 2011
- Fundamental
- Price
- NUVB $2.22
- THR $28.17
- Analyst Decision
- NUVB Strong Buy
- THR
- Analyst Count
- NUVB 6
- THR 0
- Target Price
- NUVB $7.83
- THR N/A
- AVG Volume (30 Days)
- NUVB 8.4M
- THR 155.8K
- Earning Date
- NUVB 08-04-2025
- THR 08-06-2025
- Dividend Yield
- NUVB N/A
- THR N/A
- EPS Growth
- NUVB N/A
- THR 3.97
- EPS
- NUVB N/A
- THR 1.57
- Revenue
- NUVB $10,957,000.00
- THR $498,207,000.00
- Revenue This Year
- NUVB $101.21
- THR $6.11
- Revenue Next Year
- NUVB $410.28
- THR $5.40
- P/E Ratio
- NUVB N/A
- THR $18.13
- Revenue Growth
- NUVB N/A
- THR 0.72
- 52 Week Low
- NUVB $1.54
- THR $23.05
- 52 Week High
- NUVB $3.97
- THR $34.36
- Technical
- Relative Strength Index (RSI)
- NUVB 54.59
- THR 52.07
- Support Level
- NUVB $2.03
- THR $28.12
- Resistance Level
- NUVB $2.43
- THR $28.94
- Average True Range (ATR)
- NUVB 0.14
- THR 0.71
- MACD
- NUVB 0.04
- THR 0.03
- Stochastic Oscillator
- NUVB 65.32
- THR 55.47
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.